eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

A study for a 87-year old woman who takes Skelaxin, Ms Contin, Lortab

Summary: 185 female patients aged 87 (±5) who take the same drugs are studied.

This is a personalized study for a 87 year old female patient who has Fibromyalgia Syndrome. The study is created by eHealthMe based on reports from FDA and social media.


On Mar, 24, 2015: 185 females aged 81 (±5) who take Skelaxin, Ms Contin, Lortab are studied

Skelaxin, Ms Contin, Lortab outcomes

Information of the patient in this study:

Age: 81

Gender: female

Conditions: Fibromyalgia Syndrome

Drugs taking:
- Skelaxin - 800MG (metaxalone): used for 5 - 10 years
- Ms Contin - 100MG (morphine sulfate): used for 5 - 10 years
- Lortab - 500MG;10MG (acetaminophen; hydrocodone bitartrate): used for 5 - 10 years

eHealthMe real world results:

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Skelaxin is effectiven/an/an/an/an/a0.00%
(0 of 1 people)
Ms Contin is effectiven/an/a0.00%
(0 of 1 people)
(0 of 1 people)
Lortab is effectiven/an/an/a0.00%
(0 of 1 people)
(0 of 1 people)

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Pelvic AbscessRespiratory DistressDehydrationDizzinessDrug Withdrawal Syndromen/an/aNausea
Large Intestine PerforationUnresponsive To StimuliVomitingConstipationVomitingPain
Aortic AneurysmNauseaDrug Withdrawal SyndromeForgetfulnessDehydrationAnaemia
Cerebrovascular AccidentMental Status ChangesNauseaMemory ImpairmentAsthenia
Ischaemic StrokeHaemorrhageMemory ImpairmentNauseaFall
Lacunar InfarctionVomitingForgetfulnessAbdominal Pain LowerAnxiety
Cognitive DisorderHallucination, VisualDizzinessConfusional State
Speech DisorderHallucination, AuditoryConstipationRespiratory Failure
ComaCryingAbdominal Pain LowerRenal Failure
Oesophagitis HaemorrhagicSomnolenceDyspnoea

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:




You are not alone! Join a related support group:
- support group for people who have Fibromyalgia Syndrome
- support group for people who take Lortab
- support group for people who take Ms Contin
- support group for people who take Skelaxin

Recent related drug studies (Check your drugs):

Related drug interaction studies:

Drug effectiveness in real world:

Complete drug side effects:

Alternative drugs:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.